Difference between revisions of "WSI24-200-Case-4"
From MGH Learn Pathology
| Line 26: | Line 26: | ||
|status=completed | |status=completed | ||
|reasonCode=Beta-catenin | |reasonCode=Beta-catenin | ||
| − | |view= | + | |view=hide |
|identifier=772a4a09-c213-4a4b-9129-c6242cfa9460 | |identifier=772a4a09-c213-4a4b-9129-c6242cfa9460 | ||
}} | }} | ||
| Line 34: | Line 34: | ||
|status=completed | |status=completed | ||
|reasonCode=Glutamine synthetase (GS) | |reasonCode=Glutamine synthetase (GS) | ||
| − | |view= | + | |view=hide |
|identifier=1055a5c9-b133-497e-97fe-dc6ef7e8ccc8 | |identifier=1055a5c9-b133-497e-97fe-dc6ef7e8ccc8 | ||
}} | }} | ||
| Line 42: | Line 42: | ||
|status=completed | |status=completed | ||
|reasonCode=Fatty acid binding protein (FABP1) | |reasonCode=Fatty acid binding protein (FABP1) | ||
| − | |view= | + | |view=hide |
|identifier=e393dfb0-df3a-4b34-b393-60720144c931 | |identifier=e393dfb0-df3a-4b34-b393-60720144c931 | ||
}} | }} | ||
| Line 50: | Line 50: | ||
|status=completed | |status=completed | ||
|reasonCode=Serum amyloid A (SAA1) | |reasonCode=Serum amyloid A (SAA1) | ||
| − | |view= | + | |view=hide |
|identifier=69bd61e1-c10a-4239-9499-6aba2c54ebd8 | |identifier=69bd61e1-c10a-4239-9499-6aba2c54ebd8 | ||
}} | }} | ||
| Line 57: | Line 57: | ||
|frames=5 | |frames=5 | ||
|status=completed | |status=completed | ||
| − | |view= | + | |reasonCode=Serum amyloid A (SAA1) |
| + | |view=hide | ||
|identifier=a1271068-281a-4c2d-96ff-bcdd66a241b8 | |identifier=a1271068-281a-4c2d-96ff-bcdd66a241b8 | ||
}} | }} | ||
Latest revision as of 15:16, September 16, 2024
